C09991954 / invoice 20000
Species:CANINE
Breed:Japanese Spitz
Age (years):9
Diagnosis or signs:Recheck
Consult notes
Animal clinical history (3 most recent)
2026-03-05T00:00:00Z 12:09 PM
Reason: PCV / TP Bloods In HouseBlood taken for PCV/TPPCV-30TP-70LT S to O Vital Signs
2026-03-05T00:00:00Z 12:00 AM
Reason: PCV / TP Bloods In HouseAppointment Notes: Overdue remindersHISTORY: Presented for recheck and repeat PCV and total protein two days post blood transfusion (03/03/2026).Previous PCV performed at ARH on 03/03/2026 was 26. Current meds: Prednisolone 20mg, 1.25 tablets (25mg) once daily. Cyclosporine 100mg, one capsule once daily. Clopidogrel 75mg, 0.25 tablet. Gabapentin dispensed and Trazodone scripted for use prior to future visits.Vaccination: Not mentionedParasite Prevention: Not mentionedPre-existing conditions: noneAccess to toxins eg. Rodenticide: none EXAMINATION:Body Condition Score: 5/9Pain Scale (0-4): 0/4Hydration status (%): hydration clinically adequateCardiovascular: cardiac auscultation normal, normal rhythm, pulse pressures normal and synchronousRespiratory: thoracic auscultation clear sounds bilaterally, respiratory effort normal, no nasal dischargeNeurological: neurologically no significant findingsMusculoskeletal: ambulating normally, no palpable neck, spine, limb or joint painGastrointestinal:- Oral: normal, no mouth pain, dental score (1-4):not graded- Abdominal: no detectable pain on abdominal palpation- Rectal: not performedUrinary: NSFReproductive: NSFIntegument/Ears: NSFLymph Nodes: NSFEyes: NSFDemeanour/Behaviour: not discussed PROBLEM LIST:Post-transfusion monitoring. DIFFERENTIAL DIAGNOSIS/ DIAGNOSIS:IMHA DIAGNOSTICS:PCV: 30%TP: 70g/LSerum: Not performedInterpretation: PCV has improved from 26% to 30% post-transfusion. TP is within the normal range. ASSESSMENT:Kiba presented for a recheck post-blood transfusion. In-house diagnostics show an improved PCV of 30% compared to 26% on 03/03/2026. The patient is clinically stable on current immunosuppressive medication. TREATMENT: Medications dispensed:- Gabapentin full box dispensed.- Trazodone script provided for sedation for future visits. PLAN:Continue current medications (Prednisolone, Cyclosporine, Clopidogrel) at current dosages.Contact ARH/ZY to confirm the long-term medication plan, including the protocol for tapering Prednisolone (likely to commence in two weeks).Revisit scheduled for next Tuesday for re-evaluation.Home into owner's care. CLIENT COMMUNICATION:Discussed the improvement in blood results. Advised to continue all medications as prescribed.Advised on signs to monitor for, including weakness, collapse, or increased lethargy. Instructed to present to an emergency centre over the weekend if any of these signs are observed.Discussed the plan to liaise with the referral hospital for ongoing management.Gabapentin and Trazodone have been provided for use before future vet visits to reduce stress.100.00 x Gabapentin 100mg cap - WPGive two (2) capsules night before and again two (2) capsules 2 hours before arrival to vet visitSupplier:Date: 05/03/2026Client Name: Mrs Rachael Thai 1/20 Opal Street BANKS ACT 2906Patient Name: Kiba Patient Number: 7944069Species: dogGender: Male DOB: 13/04/2017Visit Number: 28481057For Schedule 8 scripts, the prescriber must rewrite all mandatory particulars in their own handwriting.Please supply the following to Mrs Thai for the express purpose of treating KibaRx: ……Trazadone 50mg…………………………...........................................Mitte: ……20 capsules…………………………............................................Directions: …Give one (1) capsules 6pm night before vet visit and again one (1) capsule two hours before arrival to vet appointment…………………5 REPEATSKEEP OUT OF REACH OF CHILDRENFOR ANIMAL TREATMENT ONLYNo. of Items: …………1……………Vet Signature: ……………………………………….Vet Name: Dr Lasanthika Thewarage ACT 2219 Vital Signs
Previous claim history (3)
| Date | Claim # | Diagnosis |
|---|---|---|
| 2026-01-09 | C09733604 | ANAEMIA - HAEMOLYTIC, IMMUNE-MEDIATED (IMHA) - PRIMARY (IDIOPATHIC) |
| 2026-01-08 | C09729929 | ANAEMIA - HAEMOLYTIC, IMMUNE-MEDIATED (IMHA) - PRIMARY (IDIOPATHIC) |
| 2026-01-08 | C09731076 | ANAEMIA - HAEMOLYTIC, IMMUNE-MEDIATED (IMHA) - PRIMARY (IDIOPATHIC) |
Line items(lines with upstream diagnosis are skipped by the model)
| Line | tstarc | Amount | Date | Upstream diagnosis |
|---|---|---|---|---|
| 10000 | tstarc_anticonvulsant_medication_-_gabapentin | 40.19 | 2026-03-05 | — |
UPM+
- DG00166ANAEMIA - HAEMOLYTIC, IMMUNE-MEDIATED (IMHA) - PRIMARY (IDIOPATHIC)DSTP_anaemia_-_immune-mediated_haemolytic
Variant (sleepy_king)
ANAEMIA - HAEMOLYTIC, IMMUNE-MEDIATED (IMHA) - PRIMARY (IDIOPATHIC)
DSTP_anaemia_-_immune-mediated_haemolytic
Conf: 0.990
Threshold: 0.17
Above: ✓
Correct?